United States Food and Drug Administration
"United States Food and Drug Administration" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc.
Descriptor ID |
D014486
|
MeSH Number(s) |
I01.409.418.750.600.650.760 N03.540.348.500.500.600.650.760
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "United States Food and Drug Administration".
Below are MeSH descriptors whose meaning is more specific than "United States Food and Drug Administration".
This graph shows the total number of publications written about "United States Food and Drug Administration" by people in this website by year, and whether "United States Food and Drug Administration" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2010 | 0 | 2 | 2 | 2011 | 0 | 1 | 1 | 2012 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "United States Food and Drug Administration" by people in Profiles.
-
Dai H, Hao J, Catley D. Retail violations of sales to minors on e-cigarettes and cigars. Public Health. 2020 Oct; 187:36-40.
-
Shakhnovich V, Meibohm B, Rosenberg A, Kierzek AM, Hasenkamp R, Funk RS, Thalhauser CJ, van der Graaf PH, Wang YC, Hamuro L. Immunogenicity in Clinical Practice and Drug Development: When is it Significant? Clin Transl Sci. 2020 03; 13(2):219-223.
-
Dai H, Catley D. The effects of assurances of voluntary compliance on retail sales to minors in the United States: 2015-2016. Prev Med. 2018 06; 111:410-414.
-
Dai H, Hao J. The effects of tobacco control policies on retailer sales to minors in the USA, 2015. Tob Control. 2018 05; 27(3):258-260.
-
Portnoy JM. It's about time for allergenic extracts to undergo review. Ann Allergy Asthma Immunol. 2012 Jul; 109(1):3-4.
-
Berde CB, Walco GA, Krane EJ, Anand KJ, Aranda JV, Craig KD, Dampier CD, Finkel JC, Grabois M, Johnston C, Lantos J, Lebel A, Maxwell LG, McGrath P, Oberlander TF, Schanberg LE, Stevens B, Taddio A, von Baeyer CL, Yaster M, Zempsky WT. Pediatric analgesic clinical trial designs, measures, and extrapolation: report of an FDA scientific workshop. Pediatrics. 2012 Feb; 129(2):354-64.
-
Emmadi R, Boonyaratanakornkit JB, Selvarangan R, Shyamala V, Zimmer BL, Williams L, Bryant B, Schutzbank T, Schoonmaker MM, Amos Wilson JA, Hall L, Pancholi P, Bernard K. Molecular methods and platforms for infectious diseases testing a review of FDA-approved and cleared assays. J Mol Diagn. 2011 Nov; 13(6):583-604.
-
Delamarter R, Zigler JE, Balderston RA, Cammisa FP, Goldstein JA, Spivak JM. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement compared with circumferential arthrodesis for the treatment of two-level lumbar degenerative disc disease: results at twenty-four months. J Bone Joint Surg Am. 2011 Apr 20; 93(8):705-15.
-
Leeder JS, Lantos J, Spielberg SP. Conference scene: pediatric pharmacogenomics and personalized medicine. Pharmacogenomics. 2010 Dec; 11(12):1691-702.
-
Lantos J. On cultural sanctions for shaping our children's genitalia. Am J Bioeth. 2010 Sep; 10(9):55-7.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|